Pre-exposure prophylaxis implementation during incarceration: Perspectives of formerly incarcerated men and women

被引:0
|
作者
Banyas, Elizabeth Anna [1 ]
Castleman, Madelaine F. [1 ]
Rahim, Husnah A. [1 ]
Okumu, Eunice [2 ]
White, Becky L. [3 ]
机构
[1] Univ North Carolina, Chapel Hill, NC 27515 USA
[2] Univ North Carolina, UNC Ctr AIDS Res, Chapel Hill, NC 27515 USA
[3] Univ North Carolina, Dept Med, Chapel Hill, NC 27515 USA
来源
PLOS ONE | 2024年 / 19卷 / 12期
关键词
HIV; TRANSMISSION; LINKAGE; PRISON; RISK;
D O I
10.1371/journal.pone.0311289
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The HIV prevalence is higher among individuals involved in the United States (U.S.) correctional system than those in general population. Despite this, people in prisons or other closed settings have poor access to the most effective biomedical prevention tool, HIV pre-exposure prophylaxis (PrEP). The purpose of this study was to explore the attitudes and beliefs of PrEP initiation in correctional facilities amongst individuals formerly in prisons or other closed settings. We conducted 13 in-depth qualitative interviews with recently released (from incarceration) clients participating in a formerly incarcerated transition program in the southern United States. We identified several themes from our interviews. These themes were 1) PrEP information during incarceration; 2) Risky behaviors during incarceration and post-release; 3) Anticipated post-release challenges to accessing PrEP. Individuals formerly in prisons or other closed settings desire more education about PrEP during incarceration. They also want to learn more about HIV prevention measures. They believe that initiating PrEP in prison would allow a seamless transition to post-release PrEP programs. In conclusion, initiating PrEP during incarceration is one strategy to increase access to PrEP among the medically underserved criminal-justice population.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Drug Resistance During HIV Pre-Exposure Prophylaxis
    Kevin M. Gibas
    Polly van den Berg
    Victoria E. Powell
    Douglas S. Krakower
    Drugs, 2019, 79 : 609 - 619
  • [42] HIV pre-exposure prophylaxis
    Sharma, Malika
    Tan, Darrell H. S.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2014, 186 (15) : E588 - E588
  • [43] PRE-EXPOSURE PROPHYLAXIS OF RABIES
    不详
    BMJ-BRITISH MEDICAL JOURNAL, 1976, 2 (6029): : 197 - 198
  • [44] Pre-exposure prophylaxis (PrEP)
    Bradshaw, Helen
    HIV MEDICINE, 2021, 22 : 47 - 47
  • [45] HIV Pre-Exposure Prophylaxis
    Liegeon, Geoffroy
    Delaugerre, Constance
    Molina, Jean-Michel
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2024, 38 (03) : 453 - 474
  • [46] HIV: Pre-exposure Prophylaxis
    Singh, Ajai Kumar
    Singh, Ashish
    Singh, Deepti
    Singh, Manish
    Singh, Pratibha
    Sharma, Abhishek
    INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE, 2012, 3 (12) : 900 - 901
  • [47] HIV pre-exposure prophylaxis
    Fougere, Edouard
    ACTUALITES PHARMACEUTIQUES, 2024, 63 (638): : 14 - 16
  • [48] Current Perspectives on the Impact of Pre-Exposure Prophylaxis Stigma Regarding Men Who Have Sex with Men in the United States
    Herron, Patrick D.
    HIV AIDS-RESEARCH AND PALLIATIVE CARE, 2020, 12 : 187 - 192
  • [49] Demand for pre-exposure prophylaxis for HIV and the impact on clinical services: Scottish men who have sex with men perspectives
    Gilson, R. I.
    Clutterbuck, D. J.
    Chen, Z. E.
    INTERNATIONAL JOURNAL OF STD & AIDS, 2018, 29 (03) : 273 - 277
  • [50] HIV pre-exposure prophylaxis
    Morin, Stephen F.
    Yamey, Gavin
    Rutherford, George W.
    BMJ-BRITISH MEDICAL JOURNAL, 2012, 345